Table 4. Cost of chronic kidney disease and end-stage kidney disease attributable to diabetes in the adult population (age >18 years) per year of analysis.
Brazil, 2010–2016.
| Year | Cost of CKD attributable to diabetes (U.S. dollars in thousands) | Cost of ESKD attributable to diabetes (U.S. dollars in thousands) | ||
|---|---|---|---|---|
| 95% confidence interval | 95% confidence interval | |||
| 2010 | 1,415 | 1,179 to 1,666 | 136,677 | 128,340 to 140,744 |
| 2011 | 1,543 | 1,285 to 1,816 | 149,044 | 139,926 to 153,479 |
| 2012 | 1,882 | 1,567 to 2,215 | 168,008 | 157,730 to 173,007 |
| 2013 | 2,178 | 1,814 to 2,564 | 184,813 | 173,507 to 190,312 |
| 2014 | 2,427 | 2,021 to 2,857 | 195,303 | 183,355 to 201,114 |
| 2015 | 2,411 | 2,008 to 2,838 | 202,785 | 190,379 to 208,818 |
| 2016 | 2,672 | 2,225 to 3,145 | 208,771 | 195,998 to 214,983 |
| Total | 14,528 | 12,100 to 17,102 | 1,245,402 | 1,169,210 to 4,180,812 |
| Annual mean | 2,075 | - | 177,915 | - |
Note: Cost of illness calculation based on PAR and on values reported in the SUS information systems. CKD: Chronic kidney disease; ESKD: End-stage kidney disease. Source: Unified Health System Outpatient Information System (SIA/SUS) and Hospital Information System (SIH/SUS). Brazil, 2010–2016.